| MBNAX | RLBAX | MBNAX / RLBAX | |
| Total Expense Ratio | 1.08 | 1.31 | 82% |
| Annual Report Gross Expense Ratio | 1.08 | 1.31 | 82% |
| Fund Existence | 22 years | 24 years | - |
| Gain YTD | 1.939 | 2.371 | 82% |
| Front Load | 3% | N/A | - |
| Min. Initial Investment | 15000 | 250 | 6,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 454M | 270B | 0% |
| Annual Yield % from dividends | 1.96 | 1.22 | 161% |
| Returns for 1 year | 4.96 | 10.45 | 47% |
| Returns for 3 years | 16.86 | 33.63 | 50% |
| Returns for 5 years | 4.14 | 31.35 | 13% |
| Returns for 10 years | 27.62 | 79.34 | 35% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WSBFX | 23.25 | N/A | N/A |
| Boston Trust Walden Balanced | |||
| RLBAX | 37.99 | -0.17 | -0.45% |
| American Funds American Balanced R1 | |||
| PCAQX | 85.82 | -0.63 | -0.73% |
| Principal Capital Appreciation R5 | |||
| VLIIX | 14.09 | -0.23 | -1.61% |
| Value Line Capital Appreciation Instl | |||
| RYCCX | 449.26 | -14.62 | -3.15% |
| Rydex NASDAQ-100® 2x Strategy C | |||